<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03533881</url>
  </required_header>
  <id_info>
    <org_study_id>Arom Digest Slim</org_study_id>
    <nct_id>NCT03533881</nct_id>
  </id_info>
  <brief_title>Effects of Arom Digest Slim on Metabolic Profile and Food Behaviour in Overweight Persons</brief_title>
  <official_title>Evaluation of Metabolic Effects and in Modulation of Food Behaviour of Arom Digest Slim Product in Association With Minimal Nutritional Changes in Overweight Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SC Aromaarmony SRL</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SC Aromaarmony SRL</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aims to evaluate the efficacy of Arom Digest Slim in facilitating weight
      reduction along with a series of minimal nutritional interventions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Arom Digest Slim is a blend of fish collagen and essential oils. It will be administered in a
      group of overweight females wich also undertake minimal nutritional changes. The group will
      be compared with a group following only minimal nutritional changes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2018</start_date>
  <completion_date type="Anticipated">April 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group 1: following minimal nutritional changes Group 2: following minimal nutritional changes and taking Arom Digest Slim</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Insulin Resistance index (HOMA) at 60 days (Biochemical assessment)</measure>
    <time_frame>baseline and 60 days</time_frame>
    <description>calculated from serum level of glucose and insulin: HOMA-IR = (insulin (µU/mL) x glycemia (mg/dL))/405</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Lipids at 60 days (Biochemical assessment)</measure>
    <time_frame>baseline and 60 days</time_frame>
    <description>total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides - serum level (mg/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Food behavior at 60 days (Three Factor Eating Questionnaire 18 (TEFQ 18))</measure>
    <time_frame>baseline and 60 days</time_frame>
    <description>Food behavior questionnaire: Three Factor Eating Questionnaire 18 (TEFQ 18)
Assessed parameters:
Uncontrolled eating - minimal possible value 9, maximal possible value 54 points Cognitive restriction - minimal possible value 3, maximal possible value 12 points Emotional eating - minimal possible value 5, maximal possible value 24 points Higher values represent a worse outcome. Subscales are summed to compute a total score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Bioimpedance parameters at 60 days (measured using InBody720 equipment)</measure>
    <time_frame>baseline and 60 days</time_frame>
    <description>Bioimpedance using InBody720 equipment (Biospace Co., Ltd.)
Assessed parameters:
A. Body Composition Analysis (9 items): Intracellular Water, Extracellular Water, Protein Mass (kg), Mineral Mass (kg), Body Fat Mass (kg), Total Body Water, Soft Lean Mass (kg), Fat Free Mass (kg), Weight (kg) B. Muscle-Fat Analysis(3 items): Weight (kg), Skeletal Muscle Mass (kg), Body Fat Mass (kg) C. Obesity Diagnosis: Body Mass Index(BMI, kg/m2), Percent Body Fat (%), Waist-Hip Ratio D. Lean Balance (5 items): Right Arm (kg), Left Arm (kg), Trunk (kg), Right Leg (kg), Left Leg (kg) E. Visceral Fat Area: Norma l&lt;100cm2 Over : 100~150cm2 Extremely over : &gt;150cm2 F. Weight Control(4 items): Target Weight (kg), Weight Control(kg), Fat Control(kg), Muscle Control(kg) F. Fitness Score: The Fitness Score is an arbitrary score based on the measured muscle and fat mass for the motivation of the subjects. Under 70 : Weak Type 70~90 : NormalType Over 90 : Athletic Type</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Arom Digest Slim and nutritional changes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects take collagen and follow minimal nutritional changes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nutritional changes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects only follow minimal nutritional changes</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Arom Digest Slim</intervention_name>
    <description>Arom Digest Slim is a dietary supplement approved in Romania by SNPMAPS, with notification number AA 10802/2017.
It contains: hydrolyzed fish collagen (94,8 %) and volatile oils (5,2 %): Citrus paradisi (2,40 %), Citrus aurantifolia (1,24 %), Menta avensis (0,92 %), Cinamomum zeylanicum (0,56%) Patients take 4 grams of supplement per day; the supplement is dissolved in 750 ml water and drunk throughout the day</description>
    <arm_group_label>Arom Digest Slim and nutritional changes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nutritional changes</intervention_name>
    <description>Education to increase the fruits and vegetables, decrease refined carbohydrates, decrease high fat animal products, regulation of meal programme, increase water intake to at least 1,5 liters per day</description>
    <arm_group_label>Arom Digest Slim and nutritional changes</arm_group_label>
    <arm_group_label>Nutritional changes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  females 18 to 60 years old

        Exclusion Criteria:

          -  cardiovascular, psychiatric and neurologic chronic conditions and medication

          -  acute conditions

          -  patients with hypersensitivity to any components of the product
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Monica Goia-Socol, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Endocrinology Department, University of Medicine and Pharmacy Cluj-Napoca, Romania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Monica Goia-Socol, MD, PhD</last_name>
    <phone>0740923197</phone>
    <phone_ext>004</phone_ext>
    <email>monicagoiasocol@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cornelia Chaumont, psih</last_name>
    <phone>0724269920</phone>
    <phone_ext>004</phone_ext>
    <email>corneliadecuchaumont@yahoo.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Endocrinology Department</name>
      <address>
        <city>Cluj-Napoca</city>
        <state>Cluj</state>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Goia-Socol, MD</last_name>
      <phone>0740923197</phone>
      <phone_ext>004</phone_ext>
      <email>monicagoiasocol@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Cornelia Chaumont, psih</last_name>
      <phone>0724269920</phone>
      <phone_ext>004</phone_ext>
      <email>corneliadecuchaumont@yahoo.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <reference>
    <citation>Lee EJ, Hur J, Ham SA, Jo Y, Lee S, Choi MJ, Seo HG. Fish collagen peptide inhibits the adipogenic differentiation of preadipocytes and ameliorates obesity in high fat diet-fed mice. Int J Biol Macromol. 2017 Nov;104(Pt A):281-286. doi: 10.1016/j.ijbiomac.2017.05.151. Epub 2017 Jun 9.</citation>
    <PMID>28602994</PMID>
  </reference>
  <reference>
    <citation>Subhan F, Kang HY, Lim Y, Ikram M, Baek SY, Jin S, Jeong YH, Kwak JY, Yoon S. Fish Scale Collagen Peptides Protect against CoCl(2)/TNF-α-Induced Cytotoxicity and Inflammation via Inhibition of ROS, MAPK, and NF-κB Pathways in HaCaT Cells. Oxid Med Cell Longev. 2017;2017:9703609. doi: 10.1155/2017/9703609. Epub 2017 Jun 22.</citation>
    <PMID>28717410</PMID>
  </reference>
  <reference>
    <citation>Lone J, Yun JW. Monoterpene limonene induces brown fat-like phenotype in 3T3-L1 white adipocytes. Life Sci. 2016 May 15;153:198-206. doi: 10.1016/j.lfs.2016.04.010. Epub 2016 Apr 9.</citation>
    <PMID>27071835</PMID>
  </reference>
  <reference>
    <citation>Medagama AB. The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials. Nutr J. 2015 Oct 16;14:108. doi: 10.1186/s12937-015-0098-9. Review.</citation>
    <PMID>26475130</PMID>
  </reference>
  <reference>
    <citation>Maenner K, Vahjen W, Simon O. Studies on the effects of essential-oil-based feed additives on performance, ileal nutrient digestibility, and selected bacterial groups in the gastrointestinal tract of piglets. J Anim Sci. 2011 Jul;89(7):2106-12. doi: 10.2527/jas.2010-2950. Epub 2011 Feb 25.</citation>
    <PMID>21357448</PMID>
  </reference>
  <reference>
    <citation>Boschi V, Iorio D, Margiotta N, D'Orsi P, Falconi C. The three-factor eating questionnaire in the evaluation of eating behaviour in subjects seeking participation in a dietotherapy programme. Ann Nutr Metab. 2001;45(2):72-7.</citation>
    <PMID>11359032</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2018</study_first_submitted>
  <study_first_submitted_qc>May 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2018</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>SC Aromaarmony SRL</investigator_affiliation>
    <investigator_full_name>Monica Goia-Socol</investigator_full_name>
    <investigator_title>Assist. Prof. Dr. Monica Goia-Socol, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>collagen</keyword>
  <keyword>volatile oils</keyword>
  <keyword>metabolic syndrome</keyword>
  <keyword>insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

